Evaluation of an "in vivo" PaO2 and PaCO2 monitor in the management of respiratory failure.

A commercially available gas-chromatograph (Sentorr Gas Analyzer, Ohio Medical Products, Madison, WI) was tested, featuring continuous measurement of in vivo PaO2 and PaCO2 by means of a thin, heparin-coated catheter, inserted through an indwelling arterial line. Gas tensions are displayed every 4 min. The probes had a tendency to break rather easily, and a considerable proportion of them was faulty. We measured 105 paired determinations of blood gases obtained from patients in respiratory failure requiring mechanical ventilation with a Corning IL 175 Analyzer and displayed by the Sentorr Gas Analyzer. A high correlation (p < 0.01) existed between the two sets of values, but an estimated error of 10-20% was found in the Sentorr data. After modifications of the respirator, changes of displayed values were already notable after 4 min and 90% completed by 8-12 min. The use of this device enabled us to considerably accelerate decision-making in the management of respiratory failure. Although techology still necessitates improvements, before widespread use of in vivo monitoring of PaO2 and PaCO2 is advisable, the concept has significant clinical potential and may represent a major advance in the management of respiratory failure.